Unilever Consumer Care Limited (DSE:UNILEVERCL)
Bangladesh · Delayed Price · Currency is BDT 1,989.30
+2.30 (0.12%)
At close: Sep 24, 2026
Unilever Consumer Care Market Cap
Unilever Consumer Care has a market cap or net worth of 38.34 billion as of September 25, 2026. Its market cap has decreased by -17.12% in one year.
Market Cap
38.34B
Enterprise Value
35.82B
Revenue
3.42B
Ranking
n/a
PE Ratio
62.63
Stock Price
1,989.30
ChartMarket Cap Chart
Since March 10, 2010, Unilever Consumer Care's market cap has increased from 10.02B to 38.34B, an increase of 282.70%. That is a compound annual growth rate of 8.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 38.34B | -7.51% |
| Dec 30, 2025 | 41.46B | -15.64% |
| Dec 30, 2024 | 49.14B | 26.27% |
| Dec 28, 2023 | 38.92B | 13.40% |
| Dec 29, 2022 | 34.32B | -4.30% |
| Dec 30, 2021 | 35.86B | 5.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 192.45B |
| Beximco Pharmaceuticals PLC. | 66.65B |
| Renata | 51.49B |
| Beacon Pharmaceuticals | 23.98B |
| The ACME Laboratories | 16.76B |
| Asiatic Laboratories | 12.67B |
| The IBN SINA Pharmaceutical Industry | 9.94B |
| Navana Pharmaceuticals | 6.94B |